Covaxin Vaccine
-
{
- All
- News
- Videos
-
Covid Booster Shots Off To A Slow Start In Delhi
Administering of precaution dose of COVID-19 vaccines began in Delhi on Sunday amid a steady rise in daily case count in the last few days here, even as the pace was sluggish with a few private vaccination centres starting the exercise.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
Covaxin Cleared For Children Above 12 By Drug Regulator
Bharat Biotech's COVID-19 vaccine Covaxin has been approved for emergency use on children between the ages of 12 and 18 by the Drugs Controller General of India (DCGI), sources said.
-
On Covaxin Approval For Kids, Pregnant Women, WHO Chief Scientist Says...
The clearance for using Covaxin on children will take much less time, World Health Organization (WHO) chief scientist Dr Soumya Swaminathan told NDTV after the Bharat Biotech-manufactured vaccine's Emergency Use Listing.
-
Review Of Covaxin Shot Underway, May Get Recommendation In 24 Hours: WHO Official
A World Health Organization technical advisory group was reviewing data on Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said.
-
Covishield, Covaxin Work Against Alpha, Beta, Gamma, Delta Variants: Centre
Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday.
-
Covaxin 77.8% Effective In Phase 3 Trial Data: Sources
Coronavirus: Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 - according to results of Phase III trial data approved by the DCGI's Subject Expert Committee - sources said on Tuesday afternoon.
-
Covaxin Has Reached "30 Cities In 30 Days": Bharat Biotech Amid Shortages
New shipments of Bharat Biotech's Covaxin have reached 30 cities in 30 days, the vaccine maker said this morning in a tweet as a shortage of doses continues to be a challenge in India's fight against coronavirus.
-
Covaxin Works Against UK Strain, Variant Found in India: Bharat Biotech
Bharat Biotech has said its vaccine Covaxin is effective against the aggressively virulent B.1.167 strain of Covid detected in India and the UK variant of the virus B.1.1.7.
-
Mauritius Receives 200,000 Doses Of Covaxin Vaccine From India
India sent a commercial supply of 200,000 doses of Covaxin vaccines under the 'Vaccine Maitri' initiative to Mauritius on Friday.
-
"Proud" To Be Vaccinated With Bharat Biotech's Covaxin, Says S Jaishankar
External Affairs Minister S Jaishankar today said he is proud to have taken Covaxin COVID-9 vaccine, adding that questions were raised when the indigenous vaccine manufactured by Bharat Biotech came to the market earlier this year.
-
AIIMS Worker Developed Allergic Reaction To Vaccine, Stable: Director
A security guard who was administered a shot of Covaxin at AIIMS here on Saturday was admitted at the hospital after he developed an allergic reaction as part of "severe" adverse events following immunisation.
-
Third Phase Human Trial Of Covid-19 Vaccine To Begin In Bhubaneswar Soon
The third phase of the human trial of the indigenous vaccine against COVID-19, COVAXIN, will commence at a private hospital soon, an official said.
-
Covid Booster Shots Off To A Slow Start In Delhi
Administering of precaution dose of COVID-19 vaccines began in Delhi on Sunday amid a steady rise in daily case count in the last few days here, even as the pace was sluggish with a few private vaccination centres starting the exercise.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
Covaxin Cleared For Children Above 12 By Drug Regulator
Bharat Biotech's COVID-19 vaccine Covaxin has been approved for emergency use on children between the ages of 12 and 18 by the Drugs Controller General of India (DCGI), sources said.
-
On Covaxin Approval For Kids, Pregnant Women, WHO Chief Scientist Says...
The clearance for using Covaxin on children will take much less time, World Health Organization (WHO) chief scientist Dr Soumya Swaminathan told NDTV after the Bharat Biotech-manufactured vaccine's Emergency Use Listing.
-
Review Of Covaxin Shot Underway, May Get Recommendation In 24 Hours: WHO Official
A World Health Organization technical advisory group was reviewing data on Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said.
-
Covishield, Covaxin Work Against Alpha, Beta, Gamma, Delta Variants: Centre
Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday.
-
Covaxin 77.8% Effective In Phase 3 Trial Data: Sources
Coronavirus: Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 - according to results of Phase III trial data approved by the DCGI's Subject Expert Committee - sources said on Tuesday afternoon.
-
Covaxin Has Reached "30 Cities In 30 Days": Bharat Biotech Amid Shortages
New shipments of Bharat Biotech's Covaxin have reached 30 cities in 30 days, the vaccine maker said this morning in a tweet as a shortage of doses continues to be a challenge in India's fight against coronavirus.
-
Covaxin Works Against UK Strain, Variant Found in India: Bharat Biotech
Bharat Biotech has said its vaccine Covaxin is effective against the aggressively virulent B.1.167 strain of Covid detected in India and the UK variant of the virus B.1.1.7.
-
Mauritius Receives 200,000 Doses Of Covaxin Vaccine From India
India sent a commercial supply of 200,000 doses of Covaxin vaccines under the 'Vaccine Maitri' initiative to Mauritius on Friday.
-
"Proud" To Be Vaccinated With Bharat Biotech's Covaxin, Says S Jaishankar
External Affairs Minister S Jaishankar today said he is proud to have taken Covaxin COVID-9 vaccine, adding that questions were raised when the indigenous vaccine manufactured by Bharat Biotech came to the market earlier this year.
-
AIIMS Worker Developed Allergic Reaction To Vaccine, Stable: Director
A security guard who was administered a shot of Covaxin at AIIMS here on Saturday was admitted at the hospital after he developed an allergic reaction as part of "severe" adverse events following immunisation.
-
Third Phase Human Trial Of Covid-19 Vaccine To Begin In Bhubaneswar Soon
The third phase of the human trial of the indigenous vaccine against COVID-19, COVAXIN, will commence at a private hospital soon, an official said.
